Latest Breaking News On - Head of lobe clinical development programs - Page 1 : comparemela.com

Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding.

Philip youngFred sancilioAustralian securities exchangeClearway globalLobe sciences ltdLobe sciencesHead of lobe clinical development programsQuality chemical laboratories incNew york stock exchangeYork stock exchangeNew york stockConvertible noteQuality chemical laboratoriesClinical development programsAnnual general meeting